Howard Kim

About the Author Howard Kim


Acer Therapeutics (ACER) Receives a Hold from Needham

Needham analyst Serge Belanger maintained a Hold rating on Acer Therapeutics (ACER) today. The company’s shares closed last Friday at $3.

Needham Issues a Hold Rating on Columbia Care (CCHWF)

Needham analyst Matt McGinley assigned a Hold rating to Columbia Care (CCHWF) today. The company’s shares closed last Friday at $5.

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Global Blood Therapeutics (GBT)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Vertex Pharmaceuticals (VRTX) and Global Blood …

Analysts Offer Insights on Healthcare Companies: Equillium (EQ) and Siemens Healthineers AG (OtherSEMHF)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Equillium (EQ) and Siemens Healthineers …

Analysts Offer Insights on Technology Companies: Intel (INTC) and Prosus (OtherPROSF)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Intel (INTC) and Prosus (PROSF). Intel …

Lyra Therapeutics (LYRA) Gets a Buy Rating from William Blair

In a report issued on June 9, Tim Lugo from William Blair maintained a Buy rating on Lyra Therapeutics (LYRA). The company’s shares …

Analysts Have Conflicting Sentiments on These Conglomerates Companies: Golar LNG (GLNG), Masco (MAS) and Pentair (PNR)

Analysts have been eager to weigh in on the Conglomerates sector with new ratings on Golar LNG (GLNG), Masco (MAS) and Pentair (PNR). …

Northland Securities Sticks to Their Buy Rating for Genasys (GNSS)

In a report released today, Michael Latimore from Northland Securities maintained a Buy rating on Genasys (GNSS), with a price target of $9.00.

William Blair Initiates a Buy Rating on Merus (MRUS)

In a report issued on June 7, Matt Phipps from William Blair initiated coverage with a Buy rating on Merus (MRUS). The company’s …

Cardlytics (CDLX) Receives a Hold from Raymond James

Raymond James analyst Aaron Kessler maintained a Hold rating on Cardlytics (CDLX) yesterday. The company’s shares closed last Thursday at $107.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts